NCT06843720 · M.D. Anderson Cancer Center
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
What this study is about
To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.
View original scientific description
To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.
Interventions
BEHAVIORAL
HR-HPV Testing
Given by Interview and focus groups
Primary outcome measures
Safety and Adverse Events (AEs). Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 4.03
Time frame: Through study completion; an average of 1 year.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Populations involved in the research are:
- stakeholder advisory board members;
- patients eligible for cervical cancer screening participating in the cluster randomized stepped-wedge trial;
- patients and community members participating in formative research activities;
- providers, clinic staff, and other health system stakeholders from partnering health systems;
- Project ECHO Participants (providers, clinic staff, and other health system stakeholders from partner and non-partner institutions);
- Other Clinical Networks (providers, clinic staff and other health system stakeholders from partner and non-partner institutions) The eligibility criteria for each are: Patients eligible for cervical cancer screening:
- Currently a resident in the state of Texas
- Attend for care at a partner clinic enrolled in the study
- Women and persons with a cervix
- Due or past due for cervical cancer screening Patients and community members participating in formative research activities: • Purposively identified as a stakeholder for formative research by research staff Providers, clinic staff, and other health system stakeholders from partnering health systems:
- Employed at least part-time by a partnering health system
- Age 18+ Project ECHO Participants:
- Participate in at least one Project ECHO session
- Age 18+ Other Clinical Networks:
- Participate in at least one clinical network session
Exclusion criteria
- Patients eligible for cervical cancer screening:
- Report being currently pregnant
- History of total hysterectomy
- History of cervical cancer Other study populations: • Unable to communicate in English or Spanish Vulnerable Populations Participants/samples belonging to vulnerable populations (children, pregnant women, cognitively impaired adults, or prisoners) will be prohibited from participation.
Where
- Houston, Texas
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 23, 2026 · Source of record for eligibility and locations